Invacare Operating Expenses 2010-2023 | IVCRQ

Invacare operating expenses from 2010 to 2023. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Invacare Annual Operating Expenses
(Millions of US $)
2022 $822
2021 $897
2020 $839
2019 $938
2018 $991
2017 $1,007
2016 $1,063
2015 $1,150
2014 $1,329
2013 $1,375
2012 $1,407
2011 $1,462
2010 $1,337
2009 $1,612
Invacare Quarterly Operating Expenses
(Millions of US $)
2023-03-31 $176
2022-12-31 $197
2022-09-30 $204
2022-06-30 $204
2022-03-31 $218
2021-12-31 $216
2021-09-30 $249
2021-06-30 $229
2021-03-31 $202
2020-12-31 $223
2020-09-30 $209
2020-06-30 $199
2020-03-31 $209
2019-12-31 $237
2019-09-30 $233
2019-06-30 $240
2019-03-31 $228
2018-12-31 $246
2018-09-30 $250
2018-06-30 $253
2018-03-31 $242
2017-12-31 $258
2017-09-30 $257
2017-06-30 $249
2017-03-31 $242
2016-12-31 $254
2016-09-30 $266
2016-06-30 $281
2016-03-31 $263
2015-12-31 $281
2015-09-30 $284
2015-06-30 $292
2015-03-31 $293
2014-12-31 $324
2014-09-30 $346
2014-06-30 $338
2014-03-31 $321
2013-12-31 $332
2013-09-30 $342
2013-06-30 $358
2013-03-31 $344
2012-12-31 $342
2012-09-30 $357
2012-06-30 $363
2012-03-31 $346
2011-12-31 $175
2011-09-30 $431
2011-06-30 $444
2011-03-31 $411
2010-12-31 $135
2010-09-30 $408
2010-06-30 $409
2010-03-31 $386
2009-12-31 $426
2009-09-30 $409
2009-06-30 $392
2009-03-31 $384
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.000B $0.742B
Invacare Corporation is a leading manufacturer and distributor in its markets for medical equipment used in non-acute care settings. At its core, the company designs, manufactures and distributes medical devices that help people to move, breathe, rest and perform essential hygiene. The company provides clinically complex medical device solutions for congenital (e.g., cerebral palsy, muscular dystrophy, spina bifida), acquired (e.g., stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers) and degenerative (e.g., ALS, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly, bariatric) ailments. The company's products are important parts of care for people with a wide range of challenges, from those who are active and involved in work or school each day and may need additional mobility or respiratory support, to those who are cared for in residential care settings, at home and in rehabilitation centers.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Straumann Holding AG (SAUHY) Switzerland $22.515B 0.00
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47